Prestige Consumer Healthcare to acquire Breathe Right brand portfolio for $1.045B

Prestige Consumer Healthcare Inc.

Acquisition includes Breathe Right, Dimetapp, Anbesol brands; trailing revenue $200M, EBITDA $95M.
Purchase price $1.045B cash; net ~$900M after $150M anticipated tax benefits.
Implied multiple of 11.0x EBITDA (9.5x net of tax benefits); accretive to gross/EBITDA margins and EPS.
Expected pro-forma net leverage ~4.0x at closing; target below 3.0x by fiscal 2028.
Transaction expected to close in first half fiscal 2027, subject to HSR clearance.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Prestige Consumer Healthcare Inc. entered into Asset Purchase Agreement with Foundation Consumer Brands, LLC valued at $1.045 billion in cash (effective 2026-03-19).

Action: entry
Agreement: asset purchase
Counterparty: Foundation Consumer Brands, LLC
Value: $1.045 billion in cash
Effective: 2026-03-19

Exact text from the filing

On March 19, 2026, Prestige Brands, Inc. (“Purchaser”), a Delaware corporation and a wholly-owned subsidiary of Prestige Consumer Healthcare Inc. (the “Company”), entered into a definitive agreement (the “Asset Purchase Agreement”) with Foundation Consumer Brands, LLC (“Foundation”), a Delaware limited liability company. The Asset Purchase Agreement provides that, upon the terms and subject to the conditions set forth therein, Purchaser will acquire certain assets and assume certain liabilities primarily related to a portfolio of over-the-counter consumer health products, including Breathe Right® and certain other brands, for $1.045 billion in cash

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Prestige Consumer Healthcare Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-032332

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.